Cargando…
How to produce ‘marketable and profitable results for the company’: from viral interference to Roferon A
This paper looks at the commodification of interferon, marketed by Hoffmann La Roche (short: Roche) as Roferon A in 1986, as a case study that helps us understand the role of pharmaceutical industry in cancer research, the impact of molecular biology on cancer therapy, and the relationships between...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667687/ https://www.ncbi.nlm.nih.gov/pubmed/31363860 http://dx.doi.org/10.1007/s40656-019-0268-8 |